Hepatitis A is a liver infection that is very contagious and is caused by a virus called hepatitis A virus. It belongs to the Picornaviridae family. This virus activates in the liver where inflammation occurs and it affects the functioning of this organ. This results in a viral infection. Its signs and symptoms usually include malaise, nausea, vomiting, abdominal pain, dark urine, as well as jaundice, which involves yellowing of the skin and whites of the eyes. Unlike other species of viral hepatitis: hepatitis B and hepatitis C, which are associated with chronic liver diseases, hepatitis A does not cause those diseases. Its recovery is mostly self-limited within several weeks to months, and very rarely it has been found to cause acute liver failure in elderly people and people with existing liver diseases.
The hepatitis A virus spreads primarily through the fecal-oral route; thus, transmission usually occurs by consuming food or water contaminated with the feces of an infected person. This can be seen in poor sanitation conditions or proper hygiene practices. The virus can also be transferred through direct person-to-person contact, meaning if an infected person prepares food or drinks that other people may consume, or very close personal activities can lead to transfer. The virus can be found within infected stool long before symptoms appear and up to a few weeks after recovery, meaning it is very contagious.
Generally, the disease is self-resolving, meaning the immune system clears the virus without specific antiviral treatment. Lifelong immunity develops against the virus after the acute infection subsides, meaning a person who has had hepatitis A cannot get it again. This makes the disease unique immunity-wise because it does not lead to a state of chronic infection or irreversible damage to the liver in most cases; this is unlike hepatitis B or C, which are long-term and can cause serious complications in liver diseases.
Vaccination is one of the primary strategies to prevent hepatitis A. The hepatitis A vaccine prevents infection very well; and authorities recommend it, especially for at-risk populations, including travelers to endemic areas, patients with chronic liver disease, and health care and food service workers. Two doses of the vaccine are usually given 6 months apart and provide long-term benefits.
Other preventive methods besides vaccination include practicing good hygiene – washing your hands thoroughly with soap and water after using the toilet and before handling food. Ensuring proper hygiene of water and food can help reduce the risk of the virus. Improving sanitation and access to clean water are also public health interventions that will be important in preventing the spread of hepatitis A in affected areas.
Symptoms usually develop between two and six weeks after exposure to the virus. Early symptoms may be very similar to flu and may include fever, fatigue, loss of appetite, nausea, vomiting and cramps. As the infection progresses, jaundice may also develop and urine may turn dark brown while stools may be pale yellow; this is usually accompanied by. In some cases, the person may experience itching or joint pain. Not everyone infected with hepatitis A experiences all of these symptoms; some, especially very young children, may have symptoms that are not obvious or none at all.
Hepatitis is diagnosed by the history and symptoms of the patient and laboratory tests. Diagnosis is made through blood tests or serological identification for antibodies against the hepatitis A virus; antibodies identified in human serum represent the time of infection and therefore differentiate the diagnosis according to recent or old infection or previous vaccination. In the majority of cases, the infection is self-limited and supportive treatment aims to relieve symptoms. It mainly depends on rest, adequate hydration, and medications to relieve symptoms such as fever and pain.
Rarely, hepatitis A causes massive liver damage leading to acute liver failure, especially in individuals already suffering from liver diseases as well as in individuals over the age of 50. This becomes life-threatening and may require liver transplantation in extreme cases. However, most individuals infected with the hepatitis A virus recover completely within a few weeks to a few months and have no future effects.
Prevention includes vaccine and containment. The availability of hepatitis A vaccine has significantly reduced the incidence of this disease in many regions of the world. Countries where the virus is endemic have conducted vaccination campaigns to help prevent the spread of the virus, especially in high-risk populations. As a result of all these activities, many countries have seen a very sharp decline in hepatitis A cases.
Despite vaccines and all preventive measures, hepatitis A outbreaks do occur, especially in areas with poor sanitation or unadopted vaccines. However, when an outbreak occurs, public health officials may be forced to provide vaccinations, improve access to clean water, and educate the general public in hygiene practices to prevent the spread of the virus.
Hepatitis A is an acute viral hepatitis or liver infection caused by the hepatitis A virus and usually spreads through contaminated food or water. Usually, it is self-limited, and therefore people recover from it within a few weeks. Vaccination is certainly the most effective means of preventing this disease, but hygiene practices are equally important in limiting the spread of the viral disease. Hepatitis A does not cause chronic liver disease, but can sometimes cause a severe form of liver failure, known as fulminant hepatitis, especially in people with pre-existing liver conditions. Public health efforts such as vaccination and improved hygiene have been very successful in reducing the incidence of hepatitis A worldwide, although outbreaks continue to occur in some areas.
